金春股份(300877.SZ):擬使用超募資金對超募資金投資項目增加投資
格隆匯9月30日丨金春股份(300877.SZ)公佈,安徽金春無紡布股份有限公司(以下簡稱“公司”)於2021 年9 月30 日召開第二屆董事會第二十二次會議和第二屆監事會第十八次會議審議通過了《關於使用超募資金對超募資金投資項目增加投資的議案》, 同意公司根據超募資金投資項目實際建設情況,對使用超募資金投資建設年產15000 噸ES複合短纖維項目的投資金額進行調整,該項目原計劃投資金額為10692萬元,此次擬追加投資額度3127萬元,追加後的投資總額為13819萬元,追加投資金額佔原計劃投資金額的29%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.